According to research report the Microbiome Sequencing Services Market segmented by service (Sample Preparation, Sequencing, Library Preparation), type (Amplicon Sequencing, Whole Genome Sequencing), technology (Sequencing by Synthesis, Nanopore Sequencing), and end user, is projected to reach USD 555 million by 2028 from USD 284 million in 2023, at a CAGR of 14.3%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380
Key Drivers of Market Growth
Key driving factors of the microbiome sequencing services market growth include expanding applications for metagenomic sequencing, a high focus on the development of human microbiome therapeutics, and the high costs associated with sophisticated sequencing instruments. In recent years, there has been a significant increase in the demand for metagenomic sequencing in microbiome research due to its wide array of applications, such as disease diagnosis, drug discovery, and precision medicine. This is expected to boost market growth.
Market Segmentation and Trends
Service
Based on service, the microbiome sequencing services market is segmented into sample preparation services, sequencing and library preparation services, and data analysis services. Sequencing and library preparation services accounted for the largest share of the market in 2022 and are expected to dominate through the forecast period. This segment includes services crucial for microbiome analysis, where reference sequences are created for samples, or sequencing outputs are compared against existing sequences.
Type
Based on type, the global microbiome sequencing services market is segmented into amplicon sequencing, whole-genome sequencing, shotgun sequencing, and other types. The shotgun sequencing segment is expected to grow at the highest CAGR from 2023 to 2028. Advancements in data analysis solutions are driving the adoption of shotgun sequencing, which is a comprehensive approach used to analyze many organisms in complex samples and sequence all genes.
End User
Based on end user, the global microbiome sequencing services market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and other end users. The academic and research institutes segment accounted for the largest share of the market in 2022. The expanding applications of microbiome research in environmental and ecological research, veterinary research, and other research activities conducted by academic and research institutes are driving growth in this segment.
Regional Insights
The microbiome sequencing services market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, attributed to established research infrastructure, technological advancements, and demand for precision medicine. Growing recognition of the microbiome’s role in various conditions, including gastrointestinal disorders, metabolic diseases, neurodegenerative diseases, and immune-related disorders, has led to rising demand for microbiome sequencing services. This helps in understanding complex interactions between the human microbiome and host health and developing targeted interventions and therapies, contributing to regional revenue growth.
The microbiome sequencing services market is fragmented in nature with a large pool of local service providers/emerging players operating in this market. Some of the prominent market players include Charles River Laboratories (US), Eurofins Scientific (France), BGI (China), CosmosID (US), Microba (Australia), QIAGEN (Germany), Microbiome Insights (Canada), BaseClear (Netherlands), CD Genomics (US), Zymo Research (US), OraSure Technologies (US), MR DNA (US), Eremid Genomic Services (US), Clinical-Microbiomics A/S (Denmark), Novogene Co., Ltd. (China), EzBiome (US), Boster Biological Technology (US), Zifo (India), omics2view.consulting GbR (Germany), and Macrogen, Inc. (South Korea).
Get Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94324380
Conclusion
The microbiome sequencing services industry is poised for substantial growth, driven by technological advancements, increased research funding, and the growing need for precision medicine. As understanding of the microbiome’s role in health and disease deepens, demand for these services will continue to rise, supporting market expansion.
Related News & Articles:
https://www.prnewswire.com/news-releases/microbiome-sequencing-services-market-worth-555-million–marketsandmarkets-301827073.html
https://www.marketsandmarkets.com/PressReleases/microbiome-sequencing-service.asp
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
